Genovis AB (OSTO:GENO) Receivables Turnover : 1.60 (As of Dec. 2024)

View and export this data going back to 2005. Start your Free Trial

What is Genovis AB Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Genovis AB's Revenue for the three months ended in Dec. 2024 was kr27.9 Mil. Genovis AB's average Accounts Receivable for the three months ended in Dec. 2024 was kr17.4 Mil. Hence, Genovis AB's Receivables Turnover for the three months ended in Dec. 2024 was 1.60.

Genovis AB Receivables Turnover Historical Data

The historical data trend for Genovis AB's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genovis AB Receivables Turnover Chart

Genovis AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Receivables Turnover

Get a 7-Day Free Trial

6.68

8.01

7.08

9.84

7.98

Genovis AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Receivables Turnover	Get a 7-Day Free Trial															1.79	2.63	-	-	1.60

Competitive Comparison of Genovis AB's Receivables Turnover

For the Biotechnology subindustry, Genovis AB's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genovis AB's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genovis AB's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Genovis AB's Receivables Turnover falls into.

Save Embed

;

Save Embed

;

Genovis AB Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Genovis AB's Receivables Turnover for the fiscal year that ended in Dec. 2024 is calculated as

	Receivables Turnover (A: Dec. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Dec. 2024 )	/ (	(Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )
=	130.358	/ (	(15.242	+	17.428)	/	2 )
=	130.358	/	16.335
=	7.98

Genovis AB's Receivables Turnover for the quarter that ended in Dec. 2024 is calculated as

	Receivables Turnover (Q: Dec. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Dec. 2024 )	/ (	(Accounts Receivable (Q: Sep. 2024 )	+	Accounts Receivable (Q: Dec. 2024 ))	/	count )
=	27.936	/ (	(0	+	17.428)	/	1 )
=	27.936	/	17.428
=	1.60

Genovis AB (OSTO:GENO) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Genovis AB Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Genovis AB's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Genovis AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genovis AB (OSTO:GENO) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

5GV:Germany

Address

Scheelevagen 2, Box 790, Lund, SWE, SE-220 07

Website

https://www.genovis.com

Genovis AB provides enzymes and technologies for the analytical characterization and conjugation of biopharmaceuticals. The principal activities of the company are to develop, produce, and market tools for developing new drugs and diagnostics. Its product line comprises GingisREX, FabRICATOR, GlyCLICK, GingisKHAN, GlycINATOR, Fabulous, lgGZERO, and Enzymes for O-glycan. The company's main product category consists of Enzymes and Antibodies. Geographically its segments include Sweden and the rest of the world.

Genovis AB Headlines

No Headlines